Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Tian-Kang Guo
Xiang-Yong Hao
Bin Ma
Ke-Hu Yang
Yi-Ping Li
Hong-Ling Li
Yuan-Hui Gu
Hui Cai
Ya-Li Liu
Yuan Li
Wei-Peng Zhan
机构：
[1] The People’s Hospital of Gansu Province,
[2] Evidence-Based Medicine Center of Lanzhou University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Hepatocellular carcinoma; Octreotide; Liver disease; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1685 / 1692
页数：7
相关论文
共 50 条
  • [21] Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials
    Lu, Zaiming
    Wen, Feng
    Guo, Qiyong
    Liang, Hongyuan
    Mao, Xiaonan
    Sun, Hongzan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (02) : 187 - 194
  • [22] Surrogacy of Time to Progression for Overall Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Terashima, Takeshi
    Yamashita, Tatsuya
    Toyama, Tadashi
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    LIVER CANCER, 2019, 8 (02) : 130 - 139
  • [23] Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Fu, Yang
    Zhao, Xu
    Yun, Qiang
    Zhu, Xueming
    Zhu, Yong
    Li, Quanwang
    Hu, Kaiwen
    Wang, Jinwan
    Qiao, Zhanbing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 10388 - 10400
  • [24] Cinobufotalin as an effective adjuvant therapy for advanced gastric cancer: a meta-analysis of randomized controlled trials
    Sun, Huiling
    Wang, Wenxiao
    Bai, Minghua
    Liu, Dongling
    ONCOTARGETS AND THERAPY, 2019, 12 : 3139 - 3160
  • [25] Octreotide therapy for advanced hepatocellular carcinoma
    Slijkhuis, WA
    Stadheim, L
    Hassoun, ZM
    Nzeako, UC
    Kremers, WK
    Talwalkar, DA
    Gores, GJ
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (04) : 333 - 338
  • [26] Influence of Preoperative Transarterial Chemoembolization on the Prognosis for Patients with Resectable Hepatocellular Carcinoma: A Meta-Analysis of Randomized Trials
    Wang, Xiaofei
    Li, Jingdong
    Peng, Yong
    Dai, Yi
    Xu, Wei
    HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 869 - 874
  • [27] VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials
    Fei Liu
    Xianguo Chen
    Ejun Peng
    Wei Guan
    Youyuan Li
    Zhiquan Hu
    Zhangqun Ye
    Qianyuan Zhuang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2011, 31 : 799 - 806
  • [28] VEGF Pathway-targeted Therapy for Advanced Renal Cell Carcinoma: A Meta-analysis of Randomized Controlled Trials
    刘飞
    陈先国
    彭鄂军
    管维
    李有元
    胡志全
    叶章群
    庄乾元
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2011, 31 (06) : 799 - 806
  • [29] Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
    Geiger-Gritsch, Sabine
    Stollenwerk, Bjoern
    Miksad, Rebecca
    Guba, Beate
    Wild, Claudia
    Siebert, Uwe
    ONCOLOGIST, 2010, 15 (11) : 1179 - 1191
  • [30] Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials
    Liu, Yingyu
    Kou, Changgui
    Su, Yingying
    Zhang, Yangyu
    You, Yueyue
    Zhang, Lili
    Wang, Mohan
    Fu, Yingli
    Ren, Xiaojun
    Yang, Yanming
    ONCOTARGETS AND THERAPY, 2017, 10 : 2971 - 2980
12345